News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
49 Results
Section
Business (16)
Deals (2)
News (20)
Policy (2)
Tag
Earnings (11)
Events (8)
Hotbed/Location (42)
IPO (2)
People (5)
Regulatory (2)
Date
Last 365 days (47)
2024 (30)
2023 (19)
49 Results for "cencora".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Cencora’s FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products
With the increasing number of cell and gene therapy products in clinical development, Cencora’s FormularyDecisions launched a new resource designed to provide healthcare payers with centralized access to information on approved therapies and products in the pipeline.
February 8, 2024
·
3 min read
Deals
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $400 million in a private transaction.
May 22, 2024
·
3 min read
Business
Cencora Announces Leadership Succession Plan - March 12, 2024
Cencora, Inc. announced that Steven H. Collis will retire as President and Chief Executive Officer of the Company and transition to the role of Executive Chair of the Cencora Board of Directors, effective October 1, 2024.
March 12, 2024
·
5 min read
Pharm Country
Cencora Releases 2023 ESG Report
Cencora, a global healthcare company, released its 2023 Environmental, Social and Governance Report.
February 7, 2024
·
6 min read
Business
Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2024 on Wednesday, May 1, 2024, prior to the opening of trading on the New York Stock Exchange.
April 5, 2024
·
2 min read
Pharm Country
Cencora Closes $500 Million Senior Notes Offering
Cencora, Inc. announced the closing of its public offering of $500 million aggregate principal amount of its 5.125% Senior Notes due 2034, in an underwritten registered public offering.
February 7, 2024
·
4 min read
Business
Cencora Reports Fiscal 2024 First Quarter Results
Cencora, Inc. reported that in its fiscal year 2024 first quarter ended December 31, 2023, revenue increased 15.0 percent year-over-year to $72.3 billion.
January 31, 2024
·
35 min read
Pharm Country
Cencora Prices $500 Million 5.125% Senior Notes Due 2034
Cencora, Inc. announced that it priced $500 million aggregate principal amount of its 5.125% Senior Notes due 2034, in an underwritten registered public offering.
February 5, 2024
·
4 min read
Business
Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
Cencora, Inc. announced that it plans to release its results for the First Quarter of Fiscal 2024 on Wednesday, January 31, 2024, prior to the opening of trading on the New York Stock Exchange.
January 4, 2024
·
2 min read
Genetown
Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement
Sapphiros is proud to announce it has entered into a distribution agreement with Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation.
November 22, 2023
·
2 min read
1 of 5
Next
